(Q42952248)
Statements
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) (English)
Stefan K James
Michail Koutouzis
Bo Lagerqvist
Ulf Stenestrand
Bodil Svennblad